Targeting necrotic lipid release in tumors enhances immunosurveillance and cancer immunotherapy of glioblastoma



Summary

Glioblastoma, a deadly brain cancer, often evades immune responses. This research explores a new strategy to boost immunosurveillance by targeting necrotic lipid release within tumors. By inhibiting a key enzyme involved in lipid metabolism, researchers induced necrosis and subsequent release of these lipids. This release triggered a stronger immune response, characterized by increased T-cell infiltration and activation within the tumor microenvironment. The enhanced immunity, in turn, significantly improved the efficacy of cancer immunotherapy in preclinical models of glioblastoma. This suggests that targeting lipid metabolism to induce controlled necrosis could be a promising approach to overcome immune resistance and improve outcomes in glioblastoma.

Read more…

Credits: Source

This post is part of “Science/Immunology News”, Follow for more…!!!